Skip to main content
. Author manuscript; available in PMC: 2009 May 1.
Published in final edited form as: Am J Perinatol. 2008 Dec 9;26(4):317–322. doi: 10.1055/s-0028-1104743

Table 3.

Primary and Secondary Outcomes

Outcome,
n (%)
Inhaled
Nitric
Oxide (n=6)
Placebo
(n=6)
p Value
Death or BPD 3/6 (50) 6/6 (100) 0.18
Death 2/6 (33) 4/6 (67) 0.57
BPD* 2/5 (40) 2/2 (100) 0.43
Grade 3 or 4 IVH or PVL 1/5 (20) 1/2 (50) 0.46
*

This outcome is for infants who survived to 36 weeks’ post-menstrual age (five in iNO group and two in control group).

This outcome is for infants who survived to 28 days of life (five in iNO group and two in control group).